Portland, OR, April 01, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Influenza Treatment Market accounted for $861.5 million in 2018, and is projected to garner $1.22 billion by 2026, growing at a CAGR of 4.5% from 2019 to 2026.
Rise in incidences of influenza across the globe, increase in healthcare expenditure across the world, and surge in R&D investments for discovery of new drugs have boosted the growth of the global influenza treatment market. However, presence of substitutes for treatment of influenza hampers the market growth. On the contrary, high growth potential in developing economies is expected to create lucrative opportunities in the near future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/3805
The global influenza treatment market is segmented on the basis of product type, distribution channel, and geography. Based on product type, the market is divided into peramivir, zanamivir, oseltamivir phosphate, baloxavir marboxil, and others. The oseltamivir phosphate segment dominated the market in 2018, accounting for more than two-fifths of the market growth. However, the baloxavir marboxil segment is expected to portray the fastest CAGR of 4.6% during the forecast period.
On the basis of distribution channel, the market is categorized into retail pharmacy, hospital pharmacy, and others. The retail pharmacy segment held the lion’s share in 2018, accounting for nearly half of the total revenue. Moreover, the segment is anticipated to manifest the highest CAGR of 4.7% during the forecast period. This is due to strong presence of retail pharmacies around the globe.
The global influenza treatment market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the largest share in 2018, accounting for around one-third of the market. This is due to presence of huge patient base and increase in healthcare expenditure and infrastructure. However, the market across Asia-Pacific is projected to manifest the fastest CAGR of 5.6% during the forecast period, owing to surge in prevalence of influenza infection in the region.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3805
The global influenza treatment market report includes an in-depth analysis of the major market players such AstraZeneca Plc, Daiichi Sankyo Company, Limited, BioCryst Pharmaceuticals, Inc., GlaxoSmithKline Plc, F. Hoffmann-La Roche AG, Natco Pharma Limited, Mylan N.V, Sanofi, Novartis AG, and Teva Pharmaceutical Industries Limited.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
Laboratory Equipment and Disposables Market: Opportunity Analysis and Industry Forecast, 2019–2026
Pharmacogenomics Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
Surgical Mask Market: India Opportunity Analysis and Industry Forecast, 2019–2026
Bio-implants Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.